bcl-1 REARRANGEMENT AND CYCLIN D1 PROTEIN EXPRESSION IN MANTLE CELL LYMPHOMA
✍ Scribed by OTT, M. MICHAELA; HELBING, ANITA; OTT, GERMAN; BARTEK, JIRI; FISCHER, LARS; DÜRR, ALEXANDER; KREIPE, HANS; MÜLLER-HERMELINK, HANS K.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 602 KB
- Volume
- 179
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
✦ Synopsis
Centrocytic lymphoma, or mantle cell lymphoma (MCL), is characterized by a chromosomal translocation t( 11;14) (q13;q32) involving the bcl-1 locus on chromosome 11. Cyclin D1 is a cell-cycle regulatory protein essential for G 1 S transition and has been identified as a potential transforming gene affected by the translocation. In this study, 32 cases of MCL were analysed for the bcl-1 rearrangement and cyclin D1 protein expression. In 17 cases, a rearrangement a t the major translocation cluster of bcl-1 could be detected. Twentj-four cases exhibited nuclear cyclin DI expression that was not detectable in other B-cell lymphomas (n=40) or in normal B-cells. In nine MCL samples, cyclin D1 was expressed without a detectable bcl-1 rearrangement. The detection of a t(11;14) by means of classical cytogenetics in one of these cases, however, may suggest that this discrepancy could be due to chromosomal breakages outside the typical translocation cluster region. In two cases, a bcl-1 rearrangement was not accompanied by cyclin D1 expression. This study provides further evidence that cyclin D l is involved in the pathogenesis of M C L and can be exploited as a diagnostic marker in the differential diagnosis of B-cell lymphomas and in the identification of MCL.
📜 SIMILAR VOLUMES
## Abstract Cyclin D1 regulates G1 cell cycle progression by controlling the phosphorylation of the retinoblastoma protein. This pathway is frequently deregulated in many malignancies. In neuroblastoma, however, no consistent G1 cell cycle checkpoint aberrations have been found. We examined the pos
Cyclin-D1 over-expression represents one of several common alterations in the G 1 -S transition associated with malignancies. Conclusive evidences indicate that cyclin D1 is a proto-oncogene and the gene is amplified or rearranged in different tumour types. Since very little is known about aberratio
## Abstract The role of transcript variants of cyclin D1 in cancer biology is unclear. Most tumors with high levels of cyclin D1 express 2 transcripts due to alternative splicing: one full‐length transcript of 4.4 kb and one short transcript of approximately 1.7 kb. The short transcript lacks part